# Carlyle AlpInvest

> Carlyle AlpInvest is a VC fund backing Information Technology and Software. See 15 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Amsterdam, The Netherlands
- Total investments: 15
- Last investment: Apr 2026
- Lead investor: 27%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/alpinvest-partners/
- X (Twitter): https://twitter.com/alpinvestlp
- Website: http://www.alpinvest.com

Carlyle AlpInvest is a VC fund in Amsterdam focused on Information Technology and Software. AlpInvest Partners ("AlpInvest") is the private equity fund-of-funds adviser in The Carlyle Group’s Solutions business segment. AlpInvest invests across the private equity spectrum, including large and middle market buyout, growth capital, and venture capital, as well as mezzanine and distressed debt, in the United States, Europe, AsiaPacific, emerging markets and other non-traditional markets. These investments fall within three investment strategies: primary fund investments, secondary investments, and co-investments. As of June 30, 2015, AlpInvest managed over USD 47 billion of client assets on a discretionary basis. AlpInvest provides investment advisory services to pooled investment vehicles sponsored by AlpInvest and customized separately managed accounts, both of which are typically offered only to sophisticated institutional investors, such as government entities, pension funds, insurance companies and large endowments, as well as high net worth individuals and large family offices. AlpInvest employs more than 150 people and operates globally with offices in Amsterdam, New York, Indianapolis and Hong Kong.

## Contacts

5 contacts available for Carlyle AlpInvest. Shizune tracks 10 team members at Carlyle AlpInvest. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/alpinvest-partners?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Information Technology | 4 | 27% |
| Software | 3 | 20% |
| Medical | 2 | 13% |
| Health Care | 2 | 13% |
| Biotechnology | 2 | 13% |

36 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Private Equity | 5 | 33% |
| Series A | 3 | 20% |
| Series C | 2 | 13% |
| Funding Round | 2 | 13% |
| Post-IPO Equity | 2 | 13% |

6 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 6 | 40% |
| United Kingdom | 3 | 20% |
| Germany | 2 | 13% |
| India | 1 | 7% |
| Italy | 1 | 7% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Eric Hanno | Partner and Managing Director | 2 | — |
| Evan Mintz | Vice President | 0 | — |
| Julian Rampelmann | Head of Single Asset Secondaries and Deputy Head of Secondaries and Portfolio Finance | 2 | — |
| Michael Hacker | Managing Director - Partner and Global Head of Portfolio Finance | 1 | — |
| Chaimaa Rhenejar | Analyst | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Bridgepointe Technologies | Bridgepointe is a technology advisory firm that assists in bridging the gap between technological investments and business objectives.Bridgepointe assisted mid-market and enterprise clients in making more informed technology investments. |  | Private Equity | Apr 09, 2026 |  |
| ReNew | ReNew is India’s leading decarbonization solutions company listed on Nasdaq (Nasdaq: RNW, RNWWW). ReNew's clean energy portfolio of approximately 13.7GW on a gross basis as of March 31, 2023, is one of the largest globally. In addition to being a major independent power producer in India, ReNew provides end-to-end solutions in a just andinclusive manner in the areas of clean energy, value-added energy offerings through digitalization, storage, and carbon markets that increasingly are integral to addressing climate change. For more information, visit https://www.renew.com | $95M | Post-IPO Equity | Mar 16, 2026 |  |
| Essential Pharma | Essential Pharma (EP) ensures the sustainable supply of low volume, difficult to manufacture but clinically well-established pharmaceutical products to patients. These branded and generic medicines form an essential part of the pharmacopeia and represent many therapeutic areas. The company is an important partner to healthcare providers byproviding medicines that otherwise would not be available. | $942.6M | Private Equity | Dec 12, 2024 |  |
| Maison Sport | Maison Sport has been created by 3 ski instructors, Olly, Nick and Aaron - all of them share a great passion for skiing and the mountains!“At Maison Sport we are making it simple to book Ski and Snowboard instructors online. Our aim is to seamlessly connect people looking for lessons with their ideal instructor, whilst making it easy forinstructors to market themselves, so they can continue to do what they love.Currently in France, our plan is to expand across the rest of the globe, helping the best instructors impart their passion for skiing and snowboarding on likeminded customers.” | $3.8M | Series A | Sep 28, 2023 |  |
| SolarWinds | SolarWinds’ mission has been to provide purpose-built products that are designed to make jobs easier for IT professionals, MSPs, and DevOps pros. It also offers value-driven products and tools that solve a broad range of IT management challenges—whether those challenges are related to networks, servers, applications, storage, virtualization, cloud,or development operations. |  | Post-IPO Equity | Feb 16, 2021 |  |
| Integrated Dental Holdings Group | Integrated Dental Holdings operates as a holding company. Integrated Dental Holdings, through its subsidiaries, provides dental services such as x-rays, treatments, and cleaning of the mouth. |  | Private Equity | Dec 02, 2009 |  |
| VPIsystems | VPIsystems (formerly VPI Virtual Photonics) develops and markets network planning software and services for the telecommunications industry in the United States and internationally. Its products include Photonic Design Automation, a solution for the modeling and optimization of photonic components and subsystems; and OnePlan, an integrated networkplanning system that enables communications service providers, systems integrators, and manufacturers to design, plan, and implement their transition to an IP-based network. The company serves wireline, wireless, and broadband carriers; and network equipment manufacturers and optical equipment vendors. VPIsystems, Inc. has strategic alliances with Accenture, HP, Logica, and Tech Mahindra. The company was founded as VPI Virtual Photonics, Inc. in 1997 and changed its name to VPIsystems, Inc. in July 2001. VPIsystems, Inc. is based in Holmdel, New Jersey with additional offices in Europe, Asia, and Australia. | $9M |  | Mar 01, 2005 |  |
| BioXell | BioXell was founded in 2002 as a spinout of Roche Milano Ricerche, a leading biomedical research institute created ten years earlier that focused on chronic inflammatory disease and autoimmunity.The idea to create BioXell originated with Francesco Sinigaglia, founder and director of the Milan-based research institute, following a scientificcareer path that took him to the University College in London, the Basel Institute of Immunology and the Hoffmann-La Roche research units in Basel. Dr. Sinigaglia, former CEO, approached Roche with his challenging project and a year later BioXell was spun off, with $22m invested by MPM Capital, Index Ventures and Life Science Partners. | $25.2M | Series C | Oct 20, 2004 |  |
| EpiCept Corporation | EpiCept Corporation headquarters are located in Englewood Cliffs, New Jersey, with a subsidiary company, EpiCept GmbH in Munich Germany. This transatlantic presence facilitates access to European technology and markets and enhances financing and liquidity opportunities.EpiCept and its subsidiary are focused on developing novel, effective,safe and economical prescription pain products delivering drugs to a target area by using a topical delivery approach as opposed to systemic or transdermal modes. It is envisioned that EpiCept products will have significant market potential. The products are protected by an aggressive patent program. | $13M | Series C | Jan 10, 2001 |  |
| Impress Software Solutions | Impress Software Solutions, Inc. provides packaged integration applications for the integration of project management and geographical information systems with SAP. The company’s products include Impress for EPM, a packaged integration application for bridging SAP PM/PS with Microsoft project or Primavera, which synchronizes project-relateddata between the systems; and Impress for GIS, a packaged integration application, which links SAP assets with GIS features and keeps the asset information in synch between systems. It offers solutions in the areas of plant turnarounds, routine maintenance, information technology and capital projects, and spatial asset management. The company serves energy and utilities, oil and gas, aerospace and defense, chemicals, and engineering and construction industries. It has strategic partnership with Accenture, ESRI, Microsoft, Primavera, and SAP. The company was founded in 1997 and is based in Waltham, Massachusetts with additional offices in Hannover, Germany; and Huizerstraatweg, the Netherlands. Impress Software Solutions, Inc operates as a subsidiary of Impress Software Gmbh. | $19.3M |  | Jul 13, 2000 |  |

10 of 15 investments shown.

## Co-investors
- [Techno Venture Management](https://shizune.co/investors/profile/tvm-techno-venture-management) — VC Fund, 6 deals together
- [Charlesbank Capital Partners](https://shizune.co/investors/profile/charlesbank-capital-partners) — VC Fund, 2 deals together
- [Star Ventures](https://shizune.co/investors/profile/star-ventures) — VC Fund, 2 deals together
- Kearney — VC Fund, 1 deal together
- [BB Biotech Ventures](https://shizune.co/investors/profile/bb-biotech-ventures) — VC Fund, 1 deal together
- [Cipio Partners](https://shizune.co/investors/profile/cipio-partners) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Foresight Group](https://shizune.co/investors/profile/foresight-group) — VC Fund
- [YFM Equity Partners](https://shizune.co/investors/profile/yfm-equity-partners) — VC Fund
- [Fondaction](https://shizune.co/investors/profile/fondaction) — VC Fund

## FAQ

### What does Carlyle AlpInvest invest in?

Carlyle AlpInvest invests primarily in Information Technology, Software and Medical startups, most often at Private Equity and Series A stage. Most of the 15 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Carlyle AlpInvest?

Public channels for Carlyle AlpInvest include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Carlyle AlpInvest?

The team at Carlyle AlpInvest includes Eric Hanno (Partner and Managing Director), Evan Mintz (Vice President) and Julian Rampelmann (Head of Single Asset Secondaries and Deputy Head of Secondaries and Portfolio Finance), among 10 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co